Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older (there is no upper age limit)
- People with a body mass index (BMI) between 18.5 and 34.9 (a measure of body weight relative to height)
- People who own or have access to at least one electronic device, such as a computer, laptop, tablet, or smartphone
- People who have access to the internet (any type of connection)
- People who have not received nutritional counseling in the past 6 months
- People who have not worked with a personal trainer or physical education professional in the past 6 months
- People who live within 60 minutes of the research center
- People who have been diagnosed with prediabetes, confirmed by two blood sugar (HbA1c) test results between 5.7% and 6.4%, taken between 7 and 90 days apart
Who may not be able to join:
- People who have been diagnosed with diabetes, or who have taken blood sugar-lowering medication within the past three months
- People with a serious underlying illness that may shorten life expectancy or increase the risk of developing type 2 diabetes
- People with a diagnosed kidney disease
- People with a diagnosed lung disease
- People with a gastrointestinal (digestive) disease
- People who have had treatment to prevent a second heart attack or stroke (secondary cardiovascular prevention)
- People with hormonal or gland-related (endocrine) diseases
- People who have lost more than 10% of their body weight in the past 6 months (except weight loss related to having recently given birth)
- People with uncontrolled high blood pressure
- People who have been diagnosed with Polycystic Ovary Syndrome (self-reported)
- People currently being treated for tuberculosis (except those taking isoniazid as a preventive measure)
- People with conditions that may severely limit life expectancy or ability to take part in the study
- People who are pregnant or breastfeeding
- People with severe psychiatric conditions that, in the opinion of the clinical team, would make it difficult to participate
- People who drink alcohol excessively, either occasionally or regularly
- People with a specific type of heart failure (congestive heart failure) rated above Class 2 on a standard medical scale (confirm with trial site)
- People whose answers to a standard physical activity readiness questionnaire (PAR-Q) indicate they need to see a heart specialist before exercising
- People who are currently participating, or have participated in the past 6 months, in another clinical trial that could affect this study's results
- People who are likely to move away from the research center area within the next 3 years
- People who live in the same household as another participant or team member of this study (the PROVEN-DIA study)
- People who are unwilling to be randomly assigned to a treatment group or who do not agree to sign the consent form
- People who regularly take certain medications, including most corticosteroids (except creams, eye drops, or inhalers), cancer treatments, or certain psychiatric medications (confirm with trial site for full medication list)
- People who took part in the earlier pilot version of this study (NCT05689658)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Angela C Bersch-Ferreira, PhD, Hospital Beneficência Portuguesa de São Paulo
Phone: (55 11) 988295600
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of type 2 diabetes mellitus (T2DM)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.